IL6 and systemic sclerosis: This model reproduces main characteristics of SSc including anti-topoisomerase antibodies, increased levels of pro-inflammatory cytokines IL-6, and IL-17, as well as increased levels of TGF-β1 and a decrease in anti-inflammatory cytokine, IL-10[62].